(Q37156415)

18 August 2017

1 reference

title

Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies (English)

1 reference

18 August 2017

0 references

1 reference

Ulrich Förstermann

1

1 reference

18 August 2017

language of work or name

1 reference

6 May 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

5

1 reference

18 August 2017

issue

6

1 reference

18 August 2017

page(s)

338-349

1 reference

Mechanisms underlying endothelial dysfunction in diabetes mellitus

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Oxidative stress as a regulator of gene expression in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Comparative effect of ace inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Superoxide production and expression of nox family proteins in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

ATVB in focus: redox mechanisms in blood vessels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Novel NAD(P)H oxidases in the cardiovascular system

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Mitochondria, nitric oxide, and cardiovascular dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Mitochondrial integrity and function in atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with Type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

The C331A mutant of neuronal nitric-oxide synthase is defective in arginine binding.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Inactivation of Extracellular Superoxide Dismutase Contributes to the Development of High-Volume Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Nitric oxide synthase-immunoreactive nerve fibers in dog cerebral and peripheral arteries

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Glutathione Peroxidase 1 Activity and Cardiovascular Events in Patients with Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Heme oxygenase-1: a novel drug target for atherosclerotic diseases?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Induction of heme oxygenase-1 inhibits NAD(P)H oxidase activity by down-regulating cytochrome b558 expression via the reduction of heme availability.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Heme oxygenase and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Protective role of heme oxygenase in the blood vessel wall during atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Thioredoxin: a key regulator of cardiovascular homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

How does ascorbic acid prevent endothelial dysfunction?

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

L-ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

A blend of polyphenolic compounds explains the stimulatory effect of red wine on human endothelial NO synthase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Oxidative stress in arterial hypertension: role of NAD(P)H oxidase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

c-Src induces phosphorylation and translocation of p47phox: role in superoxide generation by angiotensin II in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase-2 (MMP-2) via NAD(P)H Oxidase–Derived Reactive Oxygen Species

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

New insights on oxidative stress in the artery wall.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Redox redux: revisiting PTPs and the control of cell signaling

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Vascular extracellular superoxide dismutase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Long-Term Ascorbic Acid Administration Reverses Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Neutrophil superoxide anion--generating capacity, endothelial function and oxidative stress in chronic heart failure: effects of short- and long-term vitamin C therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Antioxidant vitamins for prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

A review of the epidemiological evidence for the 'antioxidant hypothesis'

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Effect of AT1 receptor blockade on endothelial function in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Beyond lipid lowering: the role of statins in vascular protection

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Simvastatin versus ezetimibe: pleiotropic and lipid-lowering effects on endothelial function in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO1211

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO1211

1 reference

18 August 2017

1 reference